Catalyst Wire Dossier Catalyst Wire Dossier

Oxcarbazepine (novel formulation)

oxcarbazepine · Desitin Arzneimittel GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxcarbazepine (novel formulation), covering 2010-04-15 to 2010-04-15. Get the full timeline:

Most recent: Clinical Trial Update: EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy [Phase 3]

See pricing